Category Archives: Data Exclusivity

MSF calls on Japan and South Korea to drop the harmful RCEP measures

Kobe, Japan/New Delhi 22 February 2017 As 16countries negotiating the Regional Comprehensive Economic Partnership (RCEP)agreement meet next week in Kobe, Japan, for the seventeenth round of negotiations, international medical humanitarian organisation Médecins Sans Frontières (MSF) is appealing tothe Japanese and South … Continue reading

Posted in Data Exclusivity, Drug prices, Generics, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized | Leave a comment

TPP is dead, but its legacy lives on

By Arjun Jayadeva, The HinduThe Hindu | February 9, 2017 The Trans-Pacific Partnership was dead long before Donald Trump signed his executive order. But its damaging aspects, like stringent IP provisions, have just migrated to other agreements U.S. President Donald Trump’s … Continue reading

Posted in Data Exclusivity, Evergreening, Patent Term Extension, Regional Comprehensive Economic Partnership, TPP, Uncategorized | Leave a comment

Refuse trade, investment provisions that threaten access to affordable meds

Positive Malaysian Treatment Access & Advocacy Group (MTAAG+) calls on the Malaysian government to reject trade and investment agreement provisions that threaten access to affordable medicines. MTAAG+ asserts the need to make its position and demand known because of the … Continue reading

Posted in Data Exclusivity, Patent Term Extension, Regional Comprehensive Economic Partnership, TPP, TRIPS, TRIPS plus, Uncategorized | Leave a comment

India-EFTA trade deal talks to be held in January

Source: PTI | December 28, 2016 NEW DELHI: With India and the European Free Trade Association (EFTA) members resuming talks for the long-stalled proposed free trade agreement last month, senior officials of the four-nation bloc will visit here in January to … Continue reading

Posted in Data Exclusivity, EFTA-India FTA, IPR, Uncategorized | Leave a comment

President-Elect Trump Says the TPP is Dead, but What Now for IP?

By Sirena Rubinoff, IPWatchdog |December 15, 2016 President-Elect Donald Trump has announced that he will withdraw the United States from the Trans-Pacific Partnership (TPP) agreement on his first day in office. So ends more than five years of often heated negotiations … Continue reading

Posted in Data Exclusivity, Patent, Patent Term Extension, TPP, Uncategorized | Leave a comment

Regional trade meet should not pave way for monopoly in drugs: Doctors without borders

By Rosamma Thomas, TNN | December 10, 2016 JAIPUR: Negotiators from 16 countries of the Regional Comprehensive Economic Partnership (RCEP) are meeting at Tangerang, Indonesia. Doctors Without Borders/Medecins Sans Frontieres (MSF) and other health groups, days ahead of the meeting, reiterated … Continue reading

Posted in Data Exclusivity, Patent Term Extension, Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment

Australia should reject US push for even longer TPP medicine monopolies

“The Australian government should reject the push from US Republican Congress members to increase biologic medicine monopolies by seven years, even more than the extra three years which has already been agreed in the TPP text,” Dr Patricia Ranald, Convener … Continue reading

Posted in Data Exclusivity, TPP, Uncategorized | Leave a comment